This Alzheimer’s drug has already been approved for use in China. The clinical trials that could lead to approval in the U.S. have just…
Being Patient reporter Simon Spichak, who researches the role of microbes and aging at APC Microbiome Ireland, University College Cork, demystifies the microbiome and…
The ocean deep holds untapped potential when it comes to new therapies that could treat diseases like cancer and Alzheimer’s. But climate change and…
The Alzheimer’s Drug, Oligomannate, approved in China and derived from seaweed, is now being studied in the U.S. in a Phase 3, multi-center clinical…
While pharmaceutical companies have invested decades of research and billions of dollars in the quest to cure to Alzheimer’s, more than 100 experimental therapies…
An experimental “seaweed” drug called Oligomannate, which treats Alzheimer’s, is now available for patients to buy in China. Chinese officials announced conditional approval to…
Was it too good to be true? China last week awarded conditional approval for a new seaweed-based drug for Alzheimer’s, but experts in the…